To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene FNDC3BTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
447 supporting clones for gene FNDC3B back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DB076759 testis FNDC3B.a 1 to 554 2 to 555   tiling clone, capped   554/554
(100 %)
0 diff
(100 %id)
BC039297 testis FNDC3B.a 3 to 3684 1 to 3682 T179S C854W tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 3682/3682
(100 %)
5 diff
(99.9 %id)
AK314478 trachea FNDC3B.b 1 to 3712 3 to 3714 N360D S393G T448A D1083G tiling clone,   3714/3714
(100 %)
5 diff
(99.9 %id)
NM_001135095.1   FNDC3B.b 1 to 6937 3 to 6939 exact RefSeq, AAA   6939/6939
(100 %)
0 diff
(100 %id)
DB235484 trachea FNDC3B.b 1 to 570 3 to 572   capped   571/572
(99 %)
1 diff
(99.9 %id)
DA723804   FNDC3B.b 1 to 568 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
BX648340 human uterus endothel primary cell culture FNDC3B.b 4 to 3944 1 to 3940 T102A L827P P962L tiling clone, available from DKFZ,   3940/3940
(100 %)
13 diff
(99.7 %id)
AK223599 Kidney FNDC3B.c 1 to 3950 32 to 3981 P676S tiling clone,   3950/3981
(99 %)
8 diff
(99.8 %id)
NM_022763.3   FNDC3B.c 1 to 7012 1 to 7012 exact RefSeq, AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 7012/7012
(100 %)
0 diff
(100 %id)
AK127826 placenta FNDC3B.c 21 to 5083 1 to 5062 T179S available from FLJ,   5062/5062
(100 %)
4 diff
(100.0 %id)
DA850742 placenta FNDC3B.c 22 to 563 2 to 544   capped   543/543
(100 %)
1 diff
(99.9 %id)
DA864040 placenta FNDC3B.c 22 to 616 2 to 597   capped   596/596
(100 %)
1 diff
(99.9 %id)
DA863440 placenta FNDC3B.c 25 to 655 2 to 632   capped   631/631
(100 %)
2 diff
(99.7 %id)
CN289921 embryonic stem cells, DMSO-treated H9 cellline FNDC3B.c 71 to 604 1 to 534       534/534
(100 %)
0 diff
(100 %id)
BI561806 testis FNDC3B.c 140 to 853 36 to 776       525/776
(67 %)
32 diff
(95.9 %id)
TI_44350057   FNDC3B.c 140 to 853 117 to 857       648/857
(75 %)
43 diff
(95.0 %id)
AB098597   FNDC3B.c 143 to 7009 28 to 6894 T179S S208R S212A K545T tiling clone,   6867/6894
(99 %)
11 diff
(99.9 %id)
CV023688 mixed FNDC3B.c 185 to 359 1 to 175       175/389
(44 %)
1 diff
(99.8 %id)
AW748812 breast FNDC3B.c 189 to 583 1 to 399       399/399
(100 %)
6 diff
(98.5 %id)
BE082404 breast FNDC3B.c 349 to 540 193 to 1     Submitted on the opposite strand 193/232
(83 %)
6 diff
(97.5 %id)
BE082406 breast FNDC3B.c 349 to 540 193 to 1     Submitted on the opposite strand 193/232
(83 %)
6 diff
(97.5 %id)
CD652410 Embryonic Stem cells FNDC3B.c 358 to 871 210 to 722       513/835
(61 %)
71 diff
(91.5 %id)
BF083105 colon_est FNDC3B.c 435 to 586 47 to 198       152/198
(76 %)
6 diff
(97.0 %id)
ES313547 beard hair, skin FNDC3B.c 495 to 966 1 to 472       472/518
(91 %)
9 diff
(98.3 %id)
AA368153 placenta FNDC3B.c 708 to 1030 73 to 399       325/402
(80 %)
18 diff
(95.6 %id)
DA031384   FNDC3B.c 769 to 1351 2 to 585   capped   584/584
(100 %)
2 diff
(99.7 %id)
BF836244 head_neck FNDC3B.c 779 to 1315 540 to 3     Submitted on the opposite strand 538/540
(99 %)
17 diff
(96.9 %id)
BE813346 breast_normal FNDC3B.c 793 to 1369 1 to 576       576/576
(100 %)
5 diff
(99.2 %id)
AW361880 colon FNDC3B.c 866 to 1273 11 to 418       408/426
(95 %)
9 diff
(97.9 %id)
BE082198 breast FNDC3B.c 898 to 1541 1 to 644       644/644
(100 %)
0 diff
(100 %id)
BE841278 stomach_normal FNDC3B.c 1068 to 1676 39 to 645       607/646
(93 %)
11 diff
(98.3 %id)
DA861390 placenta FNDC3B.c 1071 to 1635 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
BE841251 stomach_normal FNDC3B.c 1076 to 1635 22 to 585       564/585
(96 %)
13 diff
(97.8 %id)
AY358146   FNDC3B.c 1128 to 3986 1 to 2859   AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 2859/2859
(100 %)
3 diff
(99.9 %id)
AW068289 Bone, Hip FNDC3B.c 1146 to 1512 1 to 367       367/367
(100 %)
5 diff
(98.7 %id)
BX509177   FNDC3B.c 1151 to 1765 1 to 616       616/616
(100 %)
1 diff
(99.9 %id)
BX509261   FNDC3B.c 1151 to 1683 1 to 534       534/534
(100 %)
8 diff
(98.6 %id)
BI048732 uterus FNDC3B.c 1192 to 1421 1 to 230       230/234
(98 %)
11 diff
(95.3 %id)
BF842459 head_neck FNDC3B.c 1251 to 1423 1 to 177       177/177
(100 %)
9 diff
(95.0 %id)
CN483819 eye FNDC3B.c 1317 to 1930 1 to 614       614/614
(100 %)
1 diff
(99.9 %id)
AK075220 placenta FNDC3B.c 1379 to 3988 1 to 2610   available from FLJ,   2610/2610
(100 %)
3 diff
(99.9 %id)
DA833348 placenta FNDC3B.c 1380 to 2104 2 to 730   capped   729/736
(99 %)
9 diff
(98.8 %id)
DB230726 trachea FNDC3B.c 1389 to 1996 2 to 609   capped   608/609
(99 %)
2 diff
(99.7 %id)
DA493724 brain FNDC3B.c 1447 to 2015 2 to 571   capped   570/570
(100 %)
2 diff
(99.7 %id)
BG958087 colon FNDC3B.c 1533 to 1947 428 to 15       414/428
(96 %)
1 diff
(99.8 %id)
BC033635 Skin, melanotic melanoma. FNDC3B.c 1537 to 5705 12 to 4181   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 4170/4170
(100 %)
2 diff
(100.0 %id)
BM468202 melanotic melanoma, skin FNDC3B.c 1539 to 2297 15 to 776   available from MGC,   762/1023
(74 %)
8 diff
(99.3 %id)
DB291105 uterus FNDC3B.c 1626 to 2194 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
BG957482 colon FNDC3B.c 1659 to 2024 388 to 23       365/388
(94 %)
2 diff
(99.5 %id)
BP265551 thyroid FNDC3B.c 1694 to 2274 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BP337703 coronary artery FNDC3B.c 1726 to 2308 1 to 582       582/582
(100 %)
18 diff
(97.0 %id)
BP337125 coronary artery FNDC3B.c 1734 to 2320 1 to 586       586/586
(100 %)
1 diff
(99.9 %id)
DA551691   FNDC3B.c 1735 to 2242 2 to 509   capped   508/508
(100 %)
2 diff
(99.7 %id)
BQ446022 Knee, Osteoarthritic Cartilage FNDC3B.c 1739 to 2127 724 to 336   AAA   389/706
(55 %)
5 diff
(99.3 %id)
BP243772 Liver FNDC3B.c 1766 to 2340 1 to 575       575/575
(100 %)
2 diff
(99.7 %id)
BG014703 placenta_normal FNDC3B.c 1868 to 2117 249 to 1       249/249
(100 %)
1 diff
(99.6 %id)
DA848739 placenta FNDC3B.c 1916 to 2491 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
AK027052   FNDC3B.c 2018 to 3988 1 to 1971   available from FLJ, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 1971/1971
(100 %)
0 diff
(100 %id)
CD631552   FNDC3B.c 2060 to 2669 610 to 1       610/612
(99 %)
2 diff
(99.7 %id)
CD631553   FNDC3B.c 2074 to 2670 1 to 598       598/598
(100 %)
2 diff
(99.7 %id)
AW995843 breast_normal FNDC3B.c 2092 to 2248 164 to 9     Submitted on the opposite strand 156/164
(95 %)
0 diff
(100 %id)
AW995911 breast_normal FNDC3B.c 2092 to 2248 164 to 9     Submitted on the opposite strand 156/164
(95 %)
0 diff
(100 %id)
CD631554   FNDC3B.c 2095 to 2670 1 to 576       576/576
(100 %)
0 diff
(100 %id)
CD631555   FNDC3B.c 2095 to 2648 554 to 1       554/554
(100 %)
1 diff
(99.9 %id)
CD631559   FNDC3B.c 2095 to 2669 575 to 1       575/575
(100 %)
3 diff
(99.5 %id)
CD631558   FNDC3B.c 2096 to 2670 1 to 577       577/577
(100 %)
6 diff
(99.0 %id)
BQ641865 eye, normal pigmented retinal epithelium FNDC3B.c 2140 to 3057 1 to 935       935/955
(97 %)
24 diff
(97.5 %id)
AF543840   FNDC3B.c 2300 to 3787 1 to 1488       1488/1488
(100 %)
1 diff
(100.0 %id)
CD631556   FNDC3B.c 2314 to 2670 1 to 357       357/357
(100 %)
0 diff
(100 %id)
CD631557   FNDC3B.c 2314 to 2647 334 to 1       334/334
(100 %)
2 diff
(99.5 %id)
BQ962887 leiomyosarcoma, uterus FNDC3B.c 2325 to 3115 12 to 809       798/892
(89 %)
24 diff
(97.4 %id)
AL157482 melanoma (MeWo cell line) FNDC3B.c 2353 to 5095 1 to 2744   available from DKFZ, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 2744/2744
(100 %)
2 diff
(100.0 %id)
AL121448 melanoma (MeWo cell line) FNDC3B.c 2353 to 2532 1 to 179       179/179
(100 %)
5 diff
(97.3 %id)
BQ308867 breast FNDC3B.c 2530 to 2678 1 to 148       148/148
(100 %)
3 diff
(98.0 %id)
BF909688 uterus_tumor FNDC3B.c 2537 to 2905 25 to 394       370/394
(93 %)
9 diff
(97.8 %id)
BF995430 placenta_normal FNDC3B.c 2542 to 2956 1 to 415       415/415
(100 %)
14 diff
(96.7 %id)
BF995429 placenta_normal FNDC3B.c 2545 to 2956 1 to 412       412/412
(100 %)
9 diff
(97.9 %id)
BE891158 melanotic melanoma, skin FNDC3B.c 2592 to 3338 1 to 743       743/891
(83 %)
15 diff
(98.4 %id)
W40230 Pancreas, pancreatic islet FNDC3B.c 2632 to 2964 1 to 332       332/333
(99 %)
4 diff
(98.8 %id)
AW859627 colon FNDC3B.c 2640 to 3080 564 to 124       441/564
(78 %)
5 diff
(99.2 %id)
FN109747 breast carcinoma FNDC3B.c 2818 to 2896 1 to 78       78/81
(96 %)
2 diff
(97.6 %id)
DA479474   FNDC3B.c 2829 to 3390 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
EC485499 Prostate FNDC3B.c 2831 to 2930 100 to 1       100/100
(100 %)
2 diff
(98.0 %id)
EC541797 Prostate FNDC3B.c 2831 to 2928 98 to 1       98/98
(100 %)
0 diff
(100 %id)
BG005985 placenta_normal FNDC3B.c 2834 to 3013 16 to 195       180/195
(92 %)
6 diff
(97.0 %id)
BG003731 placenta_normal FNDC3B.c 2856 to 3013 1 to 161       161/161
(100 %)
6 diff
(96.3 %id)
BI023659 marrow FNDC3B.c 2881 to 3342 462 to 1       462/462
(100 %)
6 diff
(98.8 %id)
BI002713 head_normal FNDC3B.c 2891 to 3180 384 to 98       289/384
(75 %)
0 diff
(100 %id)
BQ369045 placenta_normal FNDC3B.c 2891 to 3008 119 to 1       119/124
(95 %)
3 diff
(97.6 %id)
BQ369224 placenta_normal FNDC3B.c 2891 to 3008 119 to 1       119/124
(95 %)
3 diff
(97.6 %id)
Z25180 leg muscle, skeletal muscle FNDC3B.c 2930 to 3269 1 to 340       340/340
(100 %)
3 diff
(99.2 %id)
EC541983 Prostate FNDC3B.c 2932 to 3036 105 to 2       104/105
(99 %)
0 diff
(100 %id)
CN310282 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells FNDC3B.c 2963 to 3661 1 to 700       700/700
(100 %)
2 diff
(99.8 %id)
BI004829 head_normal FNDC3B.c 3011 to 3321 1 to 317       317/326
(97 %)
31 diff
(90.5 %id)
AW369653 breast FNDC3B.c 3012 to 3626 630 to 17       614/630
(97 %)
2 diff
(99.7 %id)
BF325728 amnion_normal FNDC3B.c 3031 to 3351 28 to 348       321/348
(92 %)
10 diff
(97.2 %id)
BF325720 amnion_normal FNDC3B.c 3038 to 3347 345 to 36       309/345
(89 %)
0 diff
(100 %id)
BF325722 amnion_normal FNDC3B.c 3038 to 3347 328 to 18       310/328
(94 %)
0 diff
(100 %id)
BF325732 amnion_normal FNDC3B.c 3038 to 3327 297 to 9       289/297
(97 %)
0 diff
(100 %id)
EC510718 Prostate FNDC3B.c 3058 to 3129 1 to 72       72/83
(86 %)
2 diff
(97.6 %id)
BF325717 amnion_normal FNDC3B.c 3103 to 3347 9 to 254       246/258
(95 %)
10 diff
(96.2 %id)
AA190444   FNDC3B.c 3234 to 3449 1 to 218       218/218
(100 %)
2 diff
(99.1 %id)
DA858126 placenta FNDC3B.c 3250 to 3824 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
DB225566 trachea FNDC3B.c 3379 to 3943 2 to 564   capped   563/563
(100 %)
2 diff
(99.7 %id)
BU632426 cell lines, Chondrosarcoma FNDC3B.c 3404 to 4005 601 to 1       601/601
(100 %)
2 diff
(99.7 %id)
BG681925 skin, squamous cell carcinoma FNDC3B.c 3488 to 4127 1 to 653       653/870
(75 %)
24 diff
(97.3 %id)
BF741924 bocio_tumor FNDC3B.c 3499 to 3639 1 to 138       138/138
(100 %)
5 diff
(96.4 %id)
CB998675 Blood vessels - aorta, basilar and artery FNDC3B.c 3543 to 4298 1 to 763       763/774
(98 %)
13 diff
(98.4 %id)
W45464 Pancreas, pancreatic islet FNDC3B.c 3564 to 3990 433 to 1       433/433
(100 %)
6 diff
(98.7 %id)
DB380027 placenta FNDC3B.c 3610 to 3988 378 to 1       378/391
(96 %)
5 diff
(98.8 %id)
DA997071   FNDC3B.c 3654 to 4136 2 to 484   capped   483/483
(100 %)
4 diff
(99.2 %id)
AI493579 adenocarcinoma, Pancreas FNDC3B.c 3683 to 3987 338 to 34   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 305/305
(100 %)
6 diff
(98.1 %id)
CB134082 Liver FNDC3B.c 3692 to 4374 1 to 682       682/682
(100 %)
7 diff
(99.0 %id)
AA247921   FNDC3B.c 3701 to 3941 1 to 233       233/233
(100 %)
12 diff
(94.9 %id)
AI536877 poorly differentiated adenocarcinoma withsignet ring cell features, stomach FNDC3B.c 3703 to 3986 294 to 11   AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 284/295
(96 %)
0 diff
(100 %id)
FN159590 breast carcinoma FNDC3B.c 3708 to 3814 108 to 1     Submitted on the opposite strand 108/109
(99 %)
6 diff
(94.5 %id)
DB226046 trachea FNDC3B.c 3722 to 4310 2 to 590   capped   589/589
(100 %)
4 diff
(99.4 %id)
AA191353   FNDC3B.c 3727 to 3982 256 to 1       256/256
(100 %)
0 diff
(100 %id)
BP333468 salivary gland FNDC3B.c 3741 to 4089 1 to 350       350/350
(100 %)
2 diff
(99.5 %id)
DA024162   FNDC3B.c 3762 to 4326 2 to 565   capped   564/564
(100 %)
4 diff
(99.3 %id)
BM452147 melanotic melanoma, skin FNDC3B.c 3770 to 4628 1 to 859       859/1057
(81 %)
20 diff
(98.2 %id)
DA471390   FNDC3B.c 3789 to 4333 2 to 547   capped   546/546
(100 %)
5 diff
(99.1 %id)
DA990378 synovial membrane tissue from rheumatioidarthritis FNDC3B.c 3826 to 4360 2 to 537   capped   536/536
(100 %)
2 diff
(99.7 %id)
DA162540 amygdala FNDC3B.c 3831 to 4406 2 to 577   capped   576/576
(100 %)
2 diff
(99.7 %id)
CN310280 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells FNDC3B.c 3837 to 4539 1 to 703       703/703
(100 %)
2 diff
(99.8 %id)
AI983662 adenocarcinoma, Pancreas FNDC3B.c 3837 to 3981 145 to 1       145/145
(100 %)
4 diff
(97.3 %id)
W60091 Pancreas, pancreatic islet FNDC3B.c 3900 to 4310 1 to 412     Submitted on the opposite strand 412/412
(100 %)
4 diff
(99.1 %id)
AW068830 Bone, Hip FNDC3B.c 3929 to 4507 12 to 592       581/592
(98 %)
6 diff
(99.0 %id)
BQ020742 lung, Metastatic Chondrosarcoma FNDC3B.c 3979 to 4653 1 to 673     Submitted on the opposite strand 673/673
(100 %)
1 diff
(99.9 %id)
BQ001313 lung, Metastatic Chondrosarcoma FNDC3B.c 3979 to 4719 1 to 739     Submitted on the opposite strand 739/739
(100 %)
2 diff
(99.8 %id)
TI_149307602   FNDC3B.c 3979 to 4939 74 to 1034     Submitted on the opposite strand 961/1099
(87 %)
41 diff
(96.3 %id)
BM979355 lung, Primary Lung Epithelial Cells FNDC3B.c 3979 to 4640 1 to 663     Submitted on the opposite strand 663/663
(100 %)
6 diff
(99.1 %id)
BG572666 placenta FNDC3B.c 4021 to 4763 1 to 750       750/798
(93 %)
33 diff
(95.9 %id)
DA864454 placenta FNDC3B.c 4043 to 4586 2 to 546   capped   545/545
(100 %)
5 diff
(99.1 %id)
DA653293   FNDC3B.c 4044 to 4637 2 to 596   capped   595/595
(100 %)
6 diff
(99.0 %id)
N41686 placenta FNDC3B.c 4064 to 4296 1 to 234       234/234
(100 %)
9 diff
(96.2 %id)
DB264410 uterus FNDC3B.c 4068 to 4638 2 to 571   capped   570/570
(100 %)
5 diff
(99.2 %id)
BM453388 melanotic melanoma, skin FNDC3B.c 4089 to 4915 36 to 865       830/954
(87 %)
14 diff
(98.6 %id)
CB218555 mandible, pooled FNDC3B.c 4113 to 4670 22 to 580     Submitted on the opposite strand 559/580
(96 %)
6 diff
(99.0 %id)
AA303663 aorta FNDC3B.c 4120 to 4388 1 to 270       270/270
(100 %)
1 diff
(99.7 %id)
R78247 placenta FNDC3B.c 4149 to 4560 1 to 424       424/424
(100 %)
20 diff
(95.3 %id)
BM991683 Bone, Subchondral Bone FNDC3B.c 4160 to 4874 731 to 19   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 713/713
(100 %)
3 diff
(99.6 %id)
T08222   FNDC3B.c 4175 to 4430 1 to 256       256/256
(100 %)
1 diff
(99.7 %id)
Z42750 brain, total brain FNDC3B.c 4176 to 4492 1 to 317       317/317
(100 %)
3 diff
(99.1 %id)
R18153 whole brain FNDC3B.c 4176 to 4586 1 to 428       428/429
(99 %)
24 diff
(94.5 %id)
R18154 whole brain FNDC3B.c 4176 to 4582 1 to 423       423/441
(95 %)
19 diff
(95.7 %id)
R18155 whole brain FNDC3B.c 4176 to 4561 1 to 406       406/406
(100 %)
25 diff
(93.9 %id)
R19895 whole brain FNDC3B.c 4178 to 4579 1 to 419       419/420
(99 %)
22 diff
(94.8 %id)
BU665386 blood FNDC3B.c 4200 to 4871 27 to 698       672/698
(96 %)
6 diff
(99.2 %id)
R67466.
matches multiple genes
placenta FNDC3B.c 4202 to 4640 1 to 442     also hits gene CSF2RB 442/442
(100 %)
5 diff
(98.9 %id)
TI_154111408   FNDC3B.c 4234 to 5083 930 to 87   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 844/954
(88 %)
11 diff
(98.9 %id)
CB218556 mandible, pooled FNDC3B.c 4254 to 4856 603 to 1     Submitted on the opposite strand 603/603
(100 %)
4 diff
(99.4 %id)
CA337278 posterior rhombomeres 5-8 (4 pooled) FNDC3B.c 4286 to 4891 641 to 35     Submitted on the opposite strand 607/641
(94 %)
0 diff
(100 %id)
AW884955 ovary FNDC3B.c 4297 to 4583 292 to 10       283/306
(92 %)
0 diff
(100 %id)
CA448438 Chondrosarcoma, Left Pubic Bone FNDC3B.c 4311 to 5083 788 to 19   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 770/770
(100 %)
6 diff
(99.3 %id)
W30796 senescent fibroblast FNDC3B.c 4328 to 4573 1 to 247       247/247
(100 %)
3 diff
(98.8 %id)
DB004660 breast, tumor tissue FNDC3B.c 4339 to 4892 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
H89788 liver and spleen FNDC3B.c 4392 to 4758 1 to 367   fully sequenced,   367/367
(100 %)
5 diff
(98.7 %id)
BM788003 stomach FNDC3B.c 4392 to 4947 1 to 556       556/556
(100 %)
2 diff
(99.7 %id)
T77700 liver and spleen FNDC3B.c 4393 to 4786 1 to 399       399/410
(97 %)
9 diff
(97.9 %id)
CB241008 Human Lung Epithelial cells, lung FNDC3B.c 4405 to 5098 712 to 19   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 694/700
(99 %)
2 diff
(99.8 %id)
CN310281 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 FNDC3B.c 4432 to 5078 9 to 654       646/654
(98 %)
6 diff
(99.1 %id)
BF909682 uterus_tumor FNDC3B.c 4434 to 4818 385 to 1     Submitted on the opposite strand 385/410
(93 %)
7 diff
(98.3 %id)
BF910514 uterus_tumor FNDC3B.c 4434 to 4780 26 to 372       347/372
(93 %)
6 diff
(98.4 %id)
BQ374975 testis_normal FNDC3B.c 4458 to 4910 1 to 448       448/448
(100 %)
20 diff
(95.6 %id)
AW841736 colon_normal FNDC3B.c 4486 to 4772 287 to 1       287/293
(97 %)
2 diff
(99.4 %id)
BQ225754 embryonal carcinoma, cell line, testis FNDC3B.c 4491 to 5253 1 to 773       773/896
(86 %)
21 diff
(97.7 %id)
R56429 whole brain FNDC3B.c 4501 to 4980 1 to 484     Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 484/487
(99 %)
10 diff
(98.0 %id)
CA311943 Human Lung Epithelial cells, lung FNDC3B.c 4512 to 5083 590 to 19   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 572/580
(98 %)
0 diff
(100 %id)
CA313523 Human Lung Epithelial cells, lung FNDC3B.c 4528 to 4874 365 to 19   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 347/377
(92 %)
4 diff
(99.0 %id)
BF444916 carcinoid, lung FNDC3B.c 4538 to 5095 562 to 5       558/562
(99 %)
0 diff
(100 %id)
DB257709 uterus FNDC3B.c 4539 to 5117 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
AI695117 colon FNDC3B.c 4557 to 5083 532 to 6       527/532
(99 %)
0 diff
(100 %id)
AI681020 carcinoid, lung FNDC3B.c 4559 to 5095 538 to 1       538/538
(100 %)
1 diff
(99.9 %id)
AI373729 Kidney FNDC3B.c 4581 to 5083 508 to 6       503/508
(99 %)
0 diff
(100 %id)
R82755 placenta FNDC3B.c 4587 to 4967 1 to 392       392/397
(98 %)
21 diff
(94.8 %id)
AA193501 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus FNDC3B.c 4591 to 5247 1 to 658       658/658
(100 %)
13 diff
(98.1 %id)
DA906759   FNDC3B.c 4609 to 5178 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA030430   FNDC3B.c 4620 to 5192 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
AI765241 2 pooled tumors (clear cell type), Kidney FNDC3B.c 4629 to 5084 469 to 15       455/469
(97 %)
0 diff
(100 %id)
R78248 placenta FNDC3B.c 4631 to 4828 198 to 1       198/198
(100 %)
0 diff
(100 %id)
BE645176 pooled FNDC3B.c 4640 to 5083 449 to 6       444/449
(98 %)
0 diff
(100 %id)
AW513404 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors FNDC3B.c 4642 to 5090 449 to 1       449/449
(100 %)
0 diff
(100 %id)
AA580268 colon, colon tumor FNDC3B.c 4658 to 5033 376 to 1       376/376
(100 %)
0 diff
(100 %id)
AI288445 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus FNDC3B.c 4662 to 5100 440 to 2       439/440
(99 %)
0 diff
(100 %id)
AA678829   FNDC3B.c 4665 to 5095 433 to 3       431/433
(99 %)
0 diff
(100 %id)
AI906429 breast FNDC3B.c 4668 to 4842 1 to 175       175/186
(94 %)
6 diff
(96.8 %id)
DA029828   FNDC3B.c 4670 to 5242 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
BE221859 Kidney FNDC3B.c 4688 to 5089 402 to 1       402/402
(100 %)
0 diff
(100 %id)
DA958981 Spleen FNDC3B.c 4689 to 5242 2 to 554   capped   553/553
(100 %)
1 diff
(99.9 %id)
AI635732 Kidney FNDC3B.c 4690 to 5089 400 to 1       400/400
(100 %)
2 diff
(99.5 %id)
CB962851 Blood vessels - aorta, basilar and artery FNDC3B.c 4699 to 5443 1 to 754       754/755
(99 %)
13 diff
(98.3 %id)
BF126529 Liver FNDC3B.c 4704 to 5246 1 to 543       543/543
(100 %)
4 diff
(99.3 %id)
AI049642   FNDC3B.c 4715 to 5097 386 to 4       383/386
(99 %)
0 diff
(100 %id)
CB163915 Liver FNDC3B.c 4717 to 5339 1 to 623       623/623
(100 %)
0 diff
(100 %id)
EL593307 epidermis, skin FNDC3B.c 4719 to 5022 28 to 331       304/356
(85 %)
3 diff
(99.2 %id)
N94450 senescent fibroblast FNDC3B.c 4727 to 5083 366 to 9       358/371
(96 %)
0 diff
(100 %id)
H89725 liver and spleen FNDC3B.c 4728 to 5059 332 to 1   fully sequenced,   332/332
(100 %)
0 diff
(100 %id)
BG120310 adenocarcinoma, cell line, Liver FNDC3B.c 4736 to 5301 1 to 566       566/566
(100 %)
0 diff
(100 %id)
BM353807 Pancreas, Purified pancreatic islet FNDC3B.c 4765 to 5220 1 to 456       456/456
(100 %)
0 diff
(100 %id)
FN149999 breast carcinoma FNDC3B.c 4775 to 4876 96 to 1     Submitted on the opposite strand 96/96
(100 %)
5 diff
(94.8 %id)
AW138567   FNDC3B.c 4776 to 5083 326 to 18   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 309/309
(100 %)
13 diff
(95.8 %id)
DB185883 liver, tumor tissue FNDC3B.c 4781 to 5366 2 to 587   capped   586/586
(100 %)
1 diff
(99.9 %id)
DA534325 brain FNDC3B.c 4792 to 5364 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
CK821473 Pancreas, Purified pancreatic islet FNDC3B.c 4804 to 5162 1 to 359     Submitted on the opposite strand 359/359
(100 %)
4 diff
(98.9 %id)
DA374348 thalamus FNDC3B.c 4810 to 5361 2 to 551   capped   550/550
(100 %)
2 diff
(99.7 %id)
BX648415 human small intestine FNDC3B.c 4831 to 7012 1 to 2180   available from DKFZ, AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 2180/2180
(100 %)
6 diff
(99.8 %id)
AW510404 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors FNDC3B.c 4846 to 5090 245 to 1       245/245
(100 %)
1 diff
(99.6 %id)
BF968853 adrenal cortex carcinoma, cell line, adrenal gland FNDC3B.c 4858 to 5504 1 to 648       648/648
(100 %)
8 diff
(98.8 %id)
AA318454 Spleen FNDC3B.c 4877 to 5084 1 to 208       208/208
(100 %)
0 diff
(100 %id)
CN290180 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 FNDC3B.c 4946 to 5559 1 to 615       615/615
(100 %)
1 diff
(99.9 %id)
BG399818 Kidney FNDC3B.c 4957 to 5684 1 to 717       717/776
(92 %)
24 diff
(97.0 %id)
C21329   FNDC3B.c 4987 to 5093 1 to 107       107/107
(100 %)
0 diff
(100 %id)
D45717 lung FNDC3B.c 4987 to 5093 1 to 107     Submitted on the opposite strand 107/107
(100 %)
0 diff
(100 %id)
DA424226   FNDC3B.c 5075 to 5646 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
CA429754 Cell Line, Chondrosarcoma FNDC3B.c 5097 to 5705 627 to 19   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 609/609
(100 %)
0 diff
(100 %id)
CB269728 adipose FNDC3B.c 5142 to 5664 1 to 519       519/519
(100 %)
9 diff
(98.3 %id)
AJ708946 heart FNDC3B.c 5182 to 5707 1 to 525       525/525
(100 %)
2 diff
(99.7 %id)
AA852328 Bone, Hip FNDC3B.c 5188 to 5479 8 to 299       292/299
(97 %)
6 diff
(98.0 %id)
D31308   FNDC3B.c 5214 to 5534 1 to 322       322/322
(100 %)
3 diff
(99.1 %id)
D31249   FNDC3B.c 5215 to 5514 1 to 300       300/300
(100 %)
0 diff
(100 %id)
BF857358 prostate_tumor FNDC3B.c 5230 to 5377 9 to 150       142/150
(94 %)
6 diff
(96.0 %id)
BG013032 placenta_normal FNDC3B.c 5230 to 5520 305 to 15       291/307
(94 %)
0 diff
(100 %id)
BF337419 brain, glioblastoma with EGFR amplification FNDC3B.c 5243 to 5881 1 to 633       633/936
(67 %)
12 diff
(98.8 %id)
BQ778100 Pancreas, Purified pancreatic islet FNDC3B.c 5273 to 5872 11 to 610       600/610
(98 %)
8 diff
(98.7 %id)
DA811920 ovary, tumor tissue FNDC3B.c 5285 to 6037 2 to 762   capped   761/792
(96 %)
16 diff
(98.0 %id)
AA344822 gall bladder FNDC3B.c 5329 to 5583 1 to 257       257/259
(99 %)
4 diff
(98.5 %id)
W52883 Pancreas, pancreatic islet FNDC3B.c 5333 to 5706 375 to 1     Submitted on the opposite strand 375/375
(100 %)
1 diff
(99.8 %id)
AW952974   FNDC3B.c 5347 to 5969 1 to 620       620/620
(100 %)
25 diff
(96.0 %id)
BQ898187 dorsal root ganglia FNDC3B.c 5349 to 5957 1 to 615       615/1077
(57 %)
14 diff
(98.8 %id)
R41701 whole brain FNDC3B.c 5356 to 5714 374 to 1       374/404
(92 %)
23 diff
(94.4 %id)
BU146462 dorsal root ganglia FNDC3B.c 5357 to 6081 1 to 732       732/900
(81 %)
11 diff
(98.8 %id)
R41700 whole brain FNDC3B.c 5367 to 5705 358 to 11       348/360
(96 %)
0 diff
(100 %id)
AA157028 uterus FNDC3B.c 5379 to 5795 1 to 421       421/421
(100 %)
4 diff
(99.1 %id)
H00607 placenta FNDC3B.c 5382 to 5672 294 to 1       294/294
(100 %)
6 diff
(98.0 %id)
BF940322 fibrotheoma, ovary FNDC3B.c 5395 to 5705 329 to 19   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 311/311
(100 %)
0 diff
(100 %id)
BE548868 cervical carcinoma cell line, cervix FNDC3B.c 5405 to 6017 47 to 660       614/664
(92 %)
25 diff
(96.3 %id)
R41702 whole brain FNDC3B.c 5423 to 5714 295 to 1       295/300
(98 %)
3 diff
(99.0 %id)
AA716383 heart FNDC3B.c 5454 to 5816 382 to 20   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 363/363
(100 %)
0 diff
(100 %id)
Z38904 brain, total brain FNDC3B.c 5468 to 5705 238 to 1       238/238
(100 %)
1 diff
(99.6 %id)
DB371181 ovary, tumor tissue FNDC3B.c 6461 to 7008 545 to 1       545/547
(99 %)
15 diff
(97.3 %id)
BQ777787 Pancreas, Purified pancreatic islet FNDC3B.c 6483 to 7012 530 to 1   tiling clone,   530/530
(100 %)
0 diff
(100 %id)
AA150403 uterus FNDC3B.c 6494 to 7008 516 to 1       516/516
(100 %)
5 diff
(99.1 %id)
R56430 whole brain FNDC3B.c 6628 to 7012 400 to 12   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 389/393
(98 %)
8 diff
(98.0 %id)
AY358367   FNDC3B.d 1 to 2904 1 to 2904 Q37H T179S tiling clone, AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 2904/2904
(100 %)
7 diff
(99.8 %id)
BG722524 testis FNDC3B.e 1 to 678 3 to 680 P102Q T111S T170S S199R tiling clone,   680/681
(99 %)
10 diff
(98.6 %id)
BC026005 lung FNDC3B.f 1 to 2588 7 to 2591 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 2588/2588
(100 %)
3 diff
(99.9 %id)
BG540059 lung FNDC3B.f 1 to 638 4 to 640   available from MGC,   640/640
(100 %)
7 diff
(99.0 %id)
BG002506 placenta_normal FNDC3B.f 419 to 1041 16 to 637       622/666
(93 %)
25 diff
(96.3 %id)
CA389683 eye, RPE/choroid FNDC3B.g-u 1 to 522 1 to 522 exact tiling clone,   522/522
(100 %)
0 diff
(100 %id)
BG221193   FNDC3B.g-u 97 to 617 40 to 562   tiling clone, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 523/562
(93 %)
6 diff
(99.0 %id)
BG210288   FNDC3B.g-u 100 to 617 1 to 519   tiling clone, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 519/519
(100 %)
9 diff
(98.3 %id)
AA766018 germinal center B cell FNDC3B.g-u 144 to 611 468 to 1       468/468
(100 %)
0 diff
(100 %id)
AW024321 thymus, pooled FNDC3B.g-u 155 to 616 473 to 12   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 462/462
(100 %)
0 diff
(100 %id)
AI627492 Kidney FNDC3B.g-u 213 to 626 414 to 1       414/414
(100 %)
2 diff
(99.6 %id)
AI652025 pooled germ cell tumors FNDC3B.g-u 216 to 623 406 to 1       406/406
(100 %)
14 diff
(96.6 %id)
AA905970 pooled FNDC3B.g-u 229 to 615 388 to 2       387/388
(99 %)
0 diff
(100 %id)
AW874177 follicular carcinoma, thyroid FNDC3B.g-u 236 to 616 389 to 8       382/389
(98 %)
0 diff
(100 %id)
AA670064 bone marrow stroma FNDC3B.g-u 248 to 467 220 to 1       220/220
(100 %)
1 diff
(99.6 %id)
CN310279 embryonic stem cells, cell lines H1, H7, andH9 FNDC3B.g-u 252 to 617 1 to 366   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 366/366
(100 %)
2 diff
(99.5 %id)
AW068035 Bone, Hip FNDC3B.g-u 267 to 615 366 to 18       349/366
(95 %)
0 diff
(100 %id)
CR988426 T-Lymphocytes FNDC3B.h-u 1 to 321 1 to 321 exact tiling clone,   321/324
(99 %)
1 diff
(99.7 %id)
DB067370 testis FNDC3B.i 1 to 553 2 to 554 exact tiling clone, capped   553/553
(100 %)
1 diff
(99.9 %id)
BF177389 blood FNDC3B.i 196 to 340 1 to 145       145/145
(100 %)
1 diff
(99.4 %id)
BG435503 placenta FNDC3B.i 507 to 1019 1 to 514   tiling clone,   514/514
(100 %)
12 diff
(97.7 %id)
AW999448 breast_normal FNDC3B.i 653 to 807 1 to 154   tiling clone,   154/157
(98 %)
6 diff
(96.2 %id)
T79019 liver and spleen FNDC3B.j 1 to 447 1 to 454 D78G E79* tiling clone,   454/464
(97 %)
28 diff
(94.0 %id)
N42276 placenta FNDC3B.j 1 to 295 1 to 296 exact tiling clone,   296/296
(100 %)
1 diff
(99.7 %id)
N32832 placenta FNDC3B.j 484 to 1067 582 to 1   tiling clone,   582/588
(98 %)
9 diff
(98.5 %id)
AW589558 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus FNDC3B.j 709 to 1071 363 to 1   tiling clone,   363/363
(100 %)
3 diff
(99.2 %id)
T79020 liver and spleen FNDC3B.j 711 to 1060 356 to 1   tiling clone,   356/380
(93 %)
11 diff
(97.2 %id)
AI290016 serous papillary carcinoma, high grade, 2pooled tumors, uterus FNDC3B.k 1 to 407 2 to 408 exact tiling clone, Submitted on the opposite strand 408/408
(100 %)
0 diff
(100 %id)
BC012204 Lung, large cell carcinoma FNDC3B.l 1 to 936 1 to 934 exact tiling clone, available from MGC, AAA   934/934
(100 %)
1 diff
(99.9 %id)
BE787895 large cell carcinoma, lung FNDC3B.l 22 to 803 1 to 772 exact available from MGC,   772/811
(95 %)
27 diff
(96.7 %id)
BG122984 adenocarcinoma, cell line, Liver FNDC3B.l 40 to 618 1 to 578 exact tiling clone,   578/579
(99 %)
6 diff
(99.0 %id)
TI_154055439   FNDC3B.l 143 to 936 887 to 96 T4P I39F L40S V41F Q42K ... AAA   794/989
(80 %)
13 diff
(98.7 %id)
CA418651 Chondrosarcoma Grade II, Left Pelvis FNDC3B.l 246 to 936 708 to 19   AAA   692/690
(100 %)
8 diff
(98.9 %id)
BQ018428 lung, Metastatic Chondrosarcoma FNDC3B.l 304 to 936 651 to 19   AAA   633/633
(100 %)
1 diff
(99.9 %id)
AW058617 pooled FNDC3B.l 422 to 941 520 to 1       520/520
(100 %)
0 diff
(100 %id)
AW515785 pooled germ cell tumors FNDC3B.l 423 to 936 514 to 1       514/514
(100 %)
3 diff
(99.5 %id)
AW514411 lung, two pooled squamous cell carcinomas FNDC3B.l 482 to 940 459 to 1       459/459
(100 %)
0 diff
(100 %id)
AW173154 pooled FNDC3B.l 487 to 946 462 to 3       460/462
(99 %)
0 diff
(100 %id)
FN170667 breast carcinoma FNDC3B.l 490 to 599 109 to 1     Submitted on the opposite strand 109/109
(100 %)
5 diff
(95.5 %id)
AW468984 poorly differentiated adenocarcinoma withsignet ring cell features, stomach FNDC3B.l 504 to 938 435 to 1       435/435
(100 %)
0 diff
(100 %id)
BX094538 heart FNDC3B.l 510 to 936 1 to 427   AAA   427/427
(100 %)
0 diff
(100 %id)
CR748025 heart FNDC3B.l 510 to 936 1 to 426   AAA   426/426
(100 %)
1 diff
(99.8 %id)
W76471 heart FNDC3B.l 510 to 928 1 to 421   fully sequenced,   421/421
(100 %)
2 diff
(99.6 %id)
W76464 heart FNDC3B.l 510 to 932 1 to 423   fully sequenced,   423/423
(100 %)
0 diff
(100 %id)
AI949175 2 pooled tumors (clear cell type), Kidney FNDC3B.l 510 to 936 437 to 11   AAA   427/427
(100 %)
0 diff
(100 %id)
CB267931 adipose FNDC3B.l 524 to 1088 1 to 564       564/564
(100 %)
2 diff
(99.7 %id)
CB268039 adipose FNDC3B.l 533 to 1088 1 to 556   tiling clone,   556/556
(100 %)
0 diff
(100 %id)
AI367245 Kidney FNDC3B.l 546 to 936 391 to 1       391/391
(100 %)
0 diff
(100 %id)
FN168531 breast carcinoma FNDC3B.l 586 to 691 1 to 101       101/101
(100 %)
5 diff
(95.1 %id)
AA759124   FNDC3B.l 602 to 943 347 to 6       342/347
(98 %)
0 diff
(100 %id)
AI752137 Bone, Hip FNDC3B.l 624 to 930 314 to 8       307/390
(78 %)
0 diff
(100 %id)
W72234 heart FNDC3B.l 719 to 935 239 to 21   fully sequenced,   219/239
(91 %)
1 diff
(99.6 %id)
W72227 heart FNDC3B.l 796 to 935 162 to 21   fully sequenced,   142/162
(87 %)
0 diff
(100 %id)
AK092465 placenta FNDC3B.m-u 1 to 1534 2 to 1534 N45S tiling clone, available from FLJ,   1534/1534
(100 %)
3 diff
(99.9 %id)
DA842594 placenta FNDC3B.m-u 1 to 558 2 to 559 N45S capped   558/558
(100 %)
1 diff
(99.9 %id)
T34599 blood, white blood cells FNDC3B.m-u 13 to 300 1 to 288 C30X V31F     288/288
(100 %)
2 diff
(99.4 %id)
AW889827 nervous_tumor FNDC3B.m-u 33 to 412 387 to 7       381/390
(97 %)
0 diff
(100 %id)
TI_154107257   FNDC3B.m-u 76 to 965 969 to 91   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 879/961
(91 %)
20 diff
(98.0 %id)
CD511828 Pooled-Skin FNDC3B.m-u 86 to 819 1 to 737   tiling clone,   737/738
(99 %)
15 diff
(98.0 %id)
CN294521 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 FNDC3B.m-u 96 to 840 1 to 744       744/744
(100 %)
2 diff
(99.8 %id)
CB987372 Pooled-Glandular FNDC3B.m-u 111 to 617 1 to 509       509/886
(57 %)
18 diff
(98.0 %id)
R21905.
matches multiple genes
placenta FNDC3B.m-u 139 to 455 1 to 326     also hits gene SH3TC2 326/326
(100 %)
14 diff
(95.8 %id)
AA314162 lung FNDC3B.m-u 178 to 420 1 to 243       243/243
(100 %)
0 diff
(100 %id)
AA907190 carcinoid, lung FNDC3B.m-u 195 to 613 1 to 419     Submitted on the opposite strand 419/419
(100 %)
0 diff
(100 %id)
AI298110 carcinoid, lung FNDC3B.m-u 195 to 604 1 to 410     Submitted on the opposite strand 410/410
(100 %)
0 diff
(100 %id)
DR422327 eye, Pterygium FNDC3B.m-u 200 to 611 1 to 411       411/420
(97 %)
4 diff
(99.1 %id)
BG676884 skin, squamous cell carcinoma FNDC3B.m-u 209 to 911 1 to 704       704/706
(99 %)
9 diff
(98.8 %id)
N40144 placenta FNDC3B.m-u 212 to 552 1 to 342       342/342
(100 %)
1 diff
(99.8 %id)
AV707945 adrenal gland FNDC3B.m-u 216 to 846 1 to 629       629/630
(99 %)
6 diff
(99.1 %id)
BE881791 large cell carcinoma, undifferentiated, lung FNDC3B.m-u 237 to 819 1 to 579       579/583
(99 %)
13 diff
(97.8 %id)
CA447017 Chondrosarcoma, Left Pubic Bone FNDC3B.m-u 265 to 965 717 to 19   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 699/699
(100 %)
2 diff
(99.8 %id)
BG679124 skin, squamous cell carcinoma FNDC3B.m-u 273 to 1111 1 to 833       833/836
(99 %)
10 diff
(98.9 %id)
BF219074 brain, glioblastoma FNDC3B.m-u 310 to 877 1 to 575       575/843
(68 %)
15 diff
(98.3 %id)
BG548034 lung FNDC3B.m-u 327 to 1090 1 to 758       758/759
(99 %)
31 diff
(96.0 %id)
BF149344 skin FNDC3B.m-u 353 to 582 229 to 1       229/229
(100 %)
1 diff
(99.6 %id)
U46440 liver cell line, pancreatic cancer FNDC3B.m-u 358 to 710 1 to 356       356/356
(100 %)
4 diff
(98.9 %id)
CB987440 Pooled-Glandular FNDC3B.m-u 371 to 1098 1 to 728       728/732
(99 %)
8 diff
(99.0 %id)
CN294959 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 FNDC3B.m-u 381 to 751 1 to 370       370/370
(100 %)
4 diff
(99.0 %id)
BE548222 cervical carcinoma cell line, cervix FNDC3B.m-u 409 to 1128 1 to 720       720/921
(78 %)
29 diff
(96.9 %id)
FN146066 breast carcinoma FNDC3B.m-u 413 to 516 101 to 1     Submitted on the opposite strand 101/101
(100 %)
3 diff
(97.1 %id)
AV689068 hepatocellular carcinoma FNDC3B.m-u 477 to 963 1 to 485       485/525
(92 %)
3 diff
(99.5 %id)
BF210339 bone marrow, from chronic myelogenous leukemia FNDC3B.m-u 493 to 1134 1 to 616       616/757
(81 %)
40 diff
(94.8 %id)
BG679881 skin, squamous cell carcinoma FNDC3B.m-u 500 to 1388 1 to 895       895/895
(100 %)
60 diff
(93.3 %id)
AA247438   FNDC3B.m-u 525 to 870 1 to 340       340/340
(100 %)
10 diff
(97.1 %id)
AA247852   FNDC3B.m-u 525 to 770 1 to 243       243/247
(98 %)
7 diff
(97.2 %id)
BF691941 melanotic melanoma, high MDR, skin FNDC3B.m-u 527 to 1278 1 to 753       753/922
(81 %)
32 diff
(96.6 %id)
BG434358 placenta FNDC3B.m-u 536 to 1190 1 to 658       658/659
(99 %)
9 diff
(98.7 %id)
BG434136 placenta FNDC3B.m-u 536 to 1287 1 to 755       755/864
(87 %)
26 diff
(97.0 %id)
CB143873 Liver FNDC3B.m-u 573 to 966 411 to 19   tiling clone, Submitted on the opposite strand 393/411
(95 %)
0 diff
(100 %id)
AW613560 Kidney FNDC3B.m-u 627 to 1110 484 to 1       484/484
(100 %)
5 diff
(99.0 %id)
AA384335 thyroid gland FNDC3B.m-u 630 to 935 1 to 305       305/305
(100 %)
1 diff
(99.7 %id)
AW966477   FNDC3B.m-u 631 to 1280 1 to 643       643/643
(100 %)
21 diff
(96.8 %id)
C03410 heart FNDC3B.m-u 634 to 960 1 to 344       344/344
(100 %)
26 diff
(92.5 %id)
C04213 heart FNDC3B.m-u 635 to 992 1 to 360       360/360
(100 %)
6 diff
(98.4 %id)
C05131 heart FNDC3B.m-u 635 to 1073 1 to 438       438/438
(100 %)
2 diff
(99.6 %id)
C05594 heart FNDC3B.m-u 635 to 975 1 to 340       340/340
(100 %)
2 diff
(99.5 %id)
BX094041 placenta FNDC3B.m-u 705 to 1376 1 to 671       671/681
(98 %)
3 diff
(99.6 %id)
TI_149293472   FNDC3B.m-u 719 to 1530 890 to 87   AAA   804/967
(83 %)
10 diff
(99.0 %id)
R66538 placenta FNDC3B.m-u 730 to 1145 1 to 428       428/443
(96 %)
23 diff
(94.9 %id)
BU682606 lung FNDC3B.m-u 730 to 1530 813 to 19   AAA   795/795
(100 %)
9 diff
(98.9 %id)
BM053035 Islets of Langerhans, Pancreas FNDC3B.m-u 744 to 1267 1 to 524   fully sequenced,   524/524
(100 %)
0 diff
(100 %id)
TI_149315017   FNDC3B.m-u 752 to 1532 864 to 92   AAA   773/949
(81 %)
11 diff
(98.9 %id)
CN479207 lung, Primary Lung Cystic Fibrosis EpithelialCells FNDC3B.m-u 752 to 1532 789 to 17   AAA   773/778
(99 %)
11 diff
(98.6 %id)
BG110103 Bone, osteosarcoma, cell line FNDC3B.m-u 760 to 1364 1 to 607       607/607
(100 %)
2 diff
(99.7 %id)
N56723.
matches multiple genes
placenta FNDC3B.m-u 766 to 1007 1 to 242     also hits gene ENPP1 242/248
(97 %)
2 diff
(99.2 %id)
N56613 placenta FNDC3B.m-u 768 to 1055 1 to 290       290/290
(100 %)
4 diff
(98.7 %id)
FN172697 breast carcinoma FNDC3B.m-u 783 to 870 84 to 1     Submitted on the opposite strand 84/87
(96 %)
2 diff
(97.8 %id)
AI674650 pooled FNDC3B.m-u 803 to 1336 544 to 10       535/544
(98 %)
0 diff
(100 %id)
BU624545 cell lines, Enchondroma FNDC3B.m-u 822 to 1526 723 to 19   AAA   705/705
(100 %)
4 diff
(99.5 %id)
TI_149285713   FNDC3B.m-u 825 to 1530 792 to 87   AAA   706/706
(100 %)
10 diff
(98.6 %id)
TI_154102679   FNDC3B.m-u 830 to 1530 788 to 93   AAA   696/793
(87 %)
9 diff
(98.9 %id)
BQ002354 Chondrosarcoma, Left Pelvis FNDC3B.m-u 831 to 1534 720 to 19   AAA   702/708
(99 %)
6 diff
(99.2 %id)
BQ006705 Chondrosarcoma, Left Pelvis FNDC3B.m-u 831 to 1530 720 to 19   AAA   702/706
(99 %)
5 diff
(99.3 %id)
R70663 placenta FNDC3B.m-u 835 to 1200 1 to 374   fully sequenced,   374/374
(100 %)
7 diff
(98.2 %id)
CB853485 Human Lung Epithelial cells, lung FNDC3B.m-u 835 to 1530 714 to 19   AAA   696/696
(100 %)
2 diff
(99.8 %id)
AW022579 cochlea, ear FNDC3B.m-u 838 to 1374 8 to 544       537/544
(98 %)
7 diff
(98.8 %id)
AW022570 cochlea, ear FNDC3B.m-u 838 to 1223 8 to 394       387/394
(98 %)
6 diff
(98.5 %id)
AW022878 cochlea, ear FNDC3B.m-u 838 to 1276 8 to 446       439/446
(98 %)
6 diff
(98.7 %id)
BM971603 lung FNDC3B.m-u 846 to 1530 703 to 19   AAA   685/685
(100 %)
7 diff
(99.0 %id)
H42341 breast FNDC3B.m-u 859 to 1201 1 to 354       354/361
(98 %)
13 diff
(96.4 %id)
AA443245.
matches multiple genes
mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus FNDC3B.m-u 880 to 1260 1 to 381     also hits gene C1QTNF2 381/381
(100 %)
0 diff
(100 %id)
CA445644 Chondrosarcoma, Left Pubic Bone FNDC3B.m-u 883 to 1530 664 to 19   tiling clone, AAA   646/646
(100 %)
2 diff
(99.7 %id)
CK126145 embryonic stem cell, Embryonic stem cell, pooled H7 ES cell line,passage 22 FNDC3B.m-u 904 to 1534 19 to 649   AAA   631/649
(97 %)
6 diff
(99.1 %id)
BM784563 lymph node, stomach FNDC3B.m-u 954 to 1375 1 to 422       422/422
(100 %)
0 diff
(100 %id)
R56702 placenta FNDC3B.m-u 960 to 1278 10 to 337   fully sequenced,   328/337
(97 %)
5 diff
(98.6 %id)
R22351 placenta FNDC3B.m-u 965 to 1354 1 to 395       395/395
(100 %)
9 diff
(97.8 %id)
D62875   FNDC3B.m-u 967 to 1312 1 to 345   fully sequenced,   345/345
(100 %)
6 diff
(98.3 %id)
AI742850 pooled FNDC3B.m-u 969 to 1530 576 to 15   AAA   562/562
(100 %)
3 diff
(99.5 %id)
AI743048 pooled FNDC3B.m-u 992 to 1533 562 to 21   AAA   542/542
(100 %)
6 diff
(98.9 %id)
AW023742 cochlea, ear FNDC3B.m-u 1002 to 1422 8 to 428       421/428
(98 %)
6 diff
(98.6 %id)
AI141784 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus FNDC3B.m-u 1005 to 1537 534 to 2       533/534
(99 %)
0 diff
(100 %id)
AI128150 uterus FNDC3B.m-u 1006 to 1534 529 to 1       529/529
(100 %)
0 diff
(100 %id)
AI633681 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus FNDC3B.m-u 1007 to 1537 532 to 2       531/532
(99 %)
0 diff
(100 %id)
AI436021 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus FNDC3B.m-u 1008 to 1531 524 to 1       524/524
(100 %)
0 diff
(100 %id)
AI651006 pooled germ cell tumors FNDC3B.m-u 1008 to 1537 531 to 2       530/531
(99 %)
0 diff
(100 %id)
AI740543 pooled FNDC3B.m-u 1009 to 1527 528 to 10       519/528
(98 %)
0 diff
(100 %id)
AW571510 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors FNDC3B.m-u 1009 to 1531 524 to 2       523/524
(99 %)
0 diff
(100 %id)
AW337959 adenocarcinoma, Pancreas FNDC3B.m-u 1012 to 1531 521 to 2       520/521
(99 %)
0 diff
(100 %id)
DB328499 placenta FNDC3B.m-u 1016 to 1534 519 to 1       519/519
(100 %)
1 diff
(99.9 %id)
BP395202 pancreatic islet FNDC3B.m-u 1021 to 1528 1 to 507     Submitted on the opposite strand 507/507
(100 %)
2 diff
(99.7 %id)
AI186663 lung FNDC3B.m-u 1025 to 1526 502 to 1       502/502
(100 %)
0 diff
(100 %id)
AI264641 Kidney FNDC3B.m-u 1027 to 1530 504 to 1       504/504
(100 %)
0 diff
(100 %id)
AI962862 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors FNDC3B.m-u 1028 to 1537 511 to 2       510/511
(99 %)
0 diff
(100 %id)
BF750096 breast_normal FNDC3B.m-u 1050 to 1231 196 to 17     Submitted on the opposite strand 180/204
(88 %)
0 diff
(100 %id)
CV320188 breast_normal FNDC3B.m-u 1050 to 1231 9 to 187       179/203
(88 %)
6 diff
(97.1 %id)
BP421914 small intestine FNDC3B.m-u 1065 to 1531 1 to 467     Submitted on the opposite strand 467/470
(99 %)
1 diff
(99.8 %id)
EH351014   FNDC3B.m-u 1068 to 1118 1 to 51       51/51
(100 %)
0 diff
(100 %id)
AI807038 pooled FNDC3B.m-u 1077 to 1526 453 to 4       450/453
(99 %)
0 diff
(100 %id)
AI417065 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus FNDC3B.m-u 1079 to 1534 471 to 16   AAA   456/456
(100 %)
0 diff
(100 %id)
AA884691 pooled FNDC3B.m-u 1080 to 1537 456 to 1       456/456
(100 %)
2 diff
(99.6 %id)
AW276569 lung, two pooled squamous cell carcinomas FNDC3B.m-u 1080 to 1531 452 to 1       452/452
(100 %)
0 diff
(100 %id)
BF111935 pooled FNDC3B.m-u 1081 to 1531 455 to 5       451/455
(99 %)
0 diff
(100 %id)
AI378229 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus FNDC3B.m-u 1084 to 1536 453 to 1       453/453
(100 %)
0 diff
(100 %id)
AA532856 colon FNDC3B.m-u 1086 to 1530 458 to 15   AAA   444/513
(86 %)
7 diff
(98.7 %id)
AI917133 Kidney, renal cell tumor FNDC3B.m-u 1086 to 1537 456 to 5       452/456
(99 %)
0 diff
(100 %id)
AW662439 colon, moderately-differentiated adenocarcinoma FNDC3B.m-u 1086 to 1526 444 to 4       441/444
(99 %)
0 diff
(100 %id)
AA605195 adrenal adenoma, adrenal gland FNDC3B.m-u 1087 to 1534 448 to 1       448/448
(100 %)
0 diff
(100 %id)
AI333917 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus FNDC3B.m-u 1088 to 1534 447 to 1       447/447
(100 %)
0 diff
(100 %id)
AA968786 Kidney, kidney tumor FNDC3B.m-u 1089 to 1537 450 to 2       449/450
(99 %)
0 diff
(100 %id)
AI080174 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus FNDC3B.m-u 1100 to 1534 446 to 12   AAA   435/435
(100 %)
1 diff
(99.8 %id)
AW002429 pooled germ cell tumors FNDC3B.m-u 1103 to 1537 436 to 2       435/436
(99 %)
0 diff
(100 %id)
CB111249 Liver FNDC3B.m-u 1112 to 1530 1 to 419   AAA   419/419
(100 %)
0 diff
(100 %id)
BF750094 breast_normal FNDC3B.m-u 1113 to 1231 1 to 117       117/133
(87 %)
8 diff
(94.0 %id)
BM830488 stomach FNDC3B.m-u 1115 to 1534 1 to 420   AAA   420/420
(100 %)
0 diff
(100 %id)
AA055243 heart FNDC3B.m-u 1116 to 1530 416 to 1       416/418
(99 %)
4 diff
(99.1 %id)
AI620092 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus FNDC3B.m-u 1116 to 1537 424 to 3       422/424
(99 %)
0 diff
(100 %id)
AW008703 brain, glioblastoma (pooled) FNDC3B.m-u 1120 to 1534 414 to 1       414/414
(100 %)
1 diff
(99.8 %id)
AW591640 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors FNDC3B.m-u 1124 to 1536 413 to 1       413/413
(100 %)
0 diff
(100 %id)
AW591636 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors FNDC3B.m-u 1127 to 1536 410 to 1       410/410
(100 %)
0 diff
(100 %id)
AA991305 breast FNDC3B.m-u 1130 to 1525 396 to 1       396/396
(100 %)
0 diff
(100 %id)
AA922656 pooled germ cell tumors FNDC3B.m-u 1132 to 1531 402 to 3       400/402
(99 %)
0 diff
(100 %id)
BF749538 breast_normal FNDC3B.m-u 1136 to 1231 1 to 97       97/113
(85 %)
3 diff
(97.4 %id)
AA971765 pooled FNDC3B.m-u 1137 to 1531 397 to 3       395/397
(99 %)
0 diff
(100 %id)
AI289507 serous papillary carcinoma, high grade, 2pooled tumors, uterus FNDC3B.m-u 1138 to 1534 423 to 27   AAA   397/397
(100 %)
0 diff
(100 %id)
AI436165 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus FNDC3B.m-u 1138 to 1537 401 to 2       400/401
(99 %)
0 diff
(100 %id)
AA813082   FNDC3B.m-u 1139 to 1539 402 to 3   tiling clone,   400/402
(99 %)
0 diff
(100 %id)
DW466529 Liver FNDC3B.m-u 1154 to 1488 17 to 351       335/351
(95 %)
10 diff
(97.2 %id)
AW149948 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors FNDC3B.m-u 1160 to 1530 381 to 11   AAA   371/371
(100 %)
1 diff
(99.8 %id)
R70664 placenta FNDC3B.m-u 1170 to 1526 365 to 1   fully sequenced,   365/365
(100 %)
4 diff
(99.0 %id)
BP418007 small intestine FNDC3B.m-u 1184 to 1535 1 to 352     Submitted on the opposite strand 352/352
(100 %)
0 diff
(100 %id)
R66539 placenta FNDC3B.m-u 1188 to 1530 347 to 1       347/352
(98 %)
5 diff
(98.6 %id)
BF439422 pooled FNDC3B.m-u 1207 to 1535 329 to 1       329/329
(100 %)
1 diff
(99.7 %id)
AW188894 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus FNDC3B.m-u 1212 to 1530 319 to 1       319/319
(100 %)
0 diff
(100 %id)
AI222001 pooled FNDC3B.m-u 1213 to 1526 334 to 21   AAA   314/314
(100 %)
0 diff
(100 %id)
AI798260 ovary, tumor, 5 pooled (see description) FNDC3B.m-u 1219 to 1530 326 to 15   AAA   312/312
(100 %)
3 diff
(99.1 %id)
AA621159 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus FNDC3B.m-u 1235 to 1537 303 to 1       303/303
(100 %)
2 diff
(99.4 %id)
AW084193 esophagus, squamous cell carcinoma FNDC3B.m-u 1237 to 1534 310 to 13   AAA   298/312
(95 %)
0 diff
(100 %id)
BM052740 Islets of Langerhans, Pancreas FNDC3B.m-u 1237 to 1539 304 to 1   fully sequenced,   304/304
(100 %)
8 diff
(97.4 %id)
R56857 placenta FNDC3B.m-u 1248 to 1530 286 to 1   fully sequenced,   286/286
(100 %)
2 diff
(99.4 %id)
D62874   FNDC3B.m-u 1282 to 1526 244 to 1   fully sequenced,   244/244
(100 %)
2 diff
(99.2 %id)
R21860.
matches multiple genes
placenta FNDC3B.m-u 1317 to 1531 218 to 2     also hits gene FEZ2 217/226
(96 %)
0 diff
(100 %id)
CN289538 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 FNDC3B.m-u 1347 to 1534 1 to 188   AAA   188/188
(100 %)
5 diff
(97.4 %id)
H43113 breast FNDC3B.m-u 1348 to 1522 175 to 1       175/175
(100 %)
0 diff
(100 %id)
AI074903 senescent fibroblast FNDC3B.m-u 1348 to 1534 208 to 22   AAA   187/187
(100 %)
0 diff
(100 %id)
AA443207 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus FNDC3B.m-u 1355 to 1534 180 to 1       180/180
(100 %)
1 diff
(99.5 %id)
AL699802 human skeletal muscle FNDC3B.n-u 1 to 495 1 to 495 L20F tiling clone,   495/495
(100 %)
5 diff
(99.0 %id)
AL699801 human skeletal muscle FNDC3B.n-u 4 to 453 1 to 450   tiling clone,   450/450
(100 %)
0 diff
(100 %id)
CA394133 eye, RPE/choroid FNDC3B.n-u 191 to 812 1 to 622   tiling clone,   622/622
(100 %)
1 diff
(99.9 %id)
CD523153 pooled FNDC3B.o 1 to 608 1 to 616 exact tiling clone,   616/770
(80 %)
19 diff
(97.6 %id)
BX951134   FNDC3B.p-u 1 to 421 1 to 421 exact tiling clone,   421/421
(100 %)
1 diff
(99.8 %id)
BX951143   FNDC3B.p-u 1 to 522 1 to 522 exact tiling clone,   522/522
(100 %)
1 diff
(99.9 %id)
CV343051 uterus_tumor FNDC3B.q-u 1 to 432 1 to 437 Q5R I16M M18V C37G T38N ... tiling clone,   437/437
(100 %)
35 diff
(92.0 %id)
AW375980 colon Gene FNDC3B, variant not shown              
AW849780 colon Gene FNDC3B, variant not shown              
AW849782 colon Gene FNDC3B, variant not shown              
AW849876 colon Gene FNDC3B, variant not shown              
AW973502   Gene FNDC3B, variant not shown         Submitted on the opposite strand    
BF747668 breast Gene FNDC3B, variant not shown              
DB311226 thalamus Gene FNDC3B, variant not shown              
DA377195 thalamus Gene FNDC3B, variant not shown       capped      
BX102814 liver and spleen Gene FNDC3B, variant not shown              
AL037100 brain Gene FNDC3B, variant not shown         This clone was ignored    
AL037101 brain Gene FNDC3B, variant not shown         This clone was ignored    
AV698964 hepatocellular carcinoma Gene FNDC3B, variant not shown              
AV700843 hepatocellular carcinoma Gene FNDC3B, variant not shown              
T87543 liver and spleen Gene FNDC3B, variant not shown              
T87544 liver and spleen Gene FNDC3B, variant not shown              
R88711 liver and spleen Gene FNDC3B, variant not shown              
R90961 liver and spleen Gene FNDC3B, variant not shown              
R88719 liver and spleen Gene FNDC3B, variant not shown              
R90972 liver and spleen Gene FNDC3B, variant not shown              
R88721 liver and spleen Gene FNDC3B, variant not shown              
R90977 liver and spleen Gene FNDC3B, variant not shown              
AA677193 liver and spleen Gene FNDC3B, variant not shown              
AA677210 liver and spleen Gene FNDC3B, variant not shown              
AA158041 Pancreas Gene FNDC3B, variant not shown         This clone was ignored    
AA158332 Pancreas Gene FNDC3B, variant not shown         This clone was ignored    
AA226720   Gene FNDC3B, variant not shown              
AA601036 Schwannoma tumor Gene FNDC3B, variant not shown              
AI354373 esophagus, squamous cell carcinoma Gene FNDC3B, variant not shown              
BG545375 lung Gene FNDC3B, variant not shown              
CA335761 anterior rhombomeres 1-4 (4 pooled) Gene FNDC3B, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
BM511711 insulinoma, Pancreas Gene FNDC3B, variant not shown       fully sequenced, AAA This clone was ignored    
BM730058 insulinoma, Pancreas Gene FNDC3B, variant not shown       fully sequenced, This clone was ignored    
BQ267949 insulinoma, Pancreas Gene FNDC3B, variant not shown       fully sequenced, AAA This clone was ignored    
BQ268218 insulinoma, Pancreas Gene FNDC3B, variant not shown       fully sequenced, This clone was ignored    
BU784349 insulinoma, Pancreas Gene FNDC3B, variant not shown       AAA This clone was ignored    
DB361821 mammary gland Gene FNDC3B, variant not shown         Suspected internal deletion, this clone was ignored    
DA647017 mammary gland Gene FNDC3B, variant not shown       capped Suspected internal deletion, this clone was ignored    
DB362130 mammary gland Gene FNDC3B, variant not shown         This clone was ignored    
DA647267 mammary gland Gene FNDC3B, variant not shown       capped This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g-u, .h-u, .i, .j, .k, .l, .m-u, .n-u, .o, .p-u, .q-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C